Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, B-Cell × Everolimus × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 16 Carcinoma, Renal Cell 10 Neuroendocrine Tumors 8 Neoplasm Metastasis 8 Recurrence 5 Endometrial Neoplasms 4 Tuberous Sclerosis 3 Neoplasms 3 Glioma 3 Glioblastoma 3 von Hippel-Lindau Disease 2 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Meningioma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Kidney Neoplasms 2 Gastro-enteropancreatic neuroendocrine tumor 2 Diffuse Intrinsic Pontine Glioma 2 Carcinoma, Hepatocellular 2 Brain Neoplasms 2 Adenoma, Islet Cell 2 Waldenstrom Macroglobulinemia 1 Vascular Malformations 1 Thyroid cancer, Hurthle cell 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Thymus Neoplasms 1 Seizures 1

Interventions

Cyclophosphamide 7 fludarabine phosphate 5 fludarabine 4 ibrutinib 3 acalabrutinib 3 Mycophenolic Acid 3 Mesna 3 Melphalan 3 venetoclax 2 pirtobrutinib 2 obinutuzumab 2 Whole-Body Irradiation 2 Tacrolimus 2 Rituximab 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Busulfan 2 Bone Marrow Transplantation 2 ARQ531 2 zanubrutinib 1 ricolinostat 1 idelalisib 1 idecabtagene vicleucel 1 Vincristine 1 Stem Cell Transplantation 1 Rabeprazole 1 Prednisone 1 Magnetic Resonance Imaging 1 Leukapheresis 1 Itraconazole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡